期刊文献+

2014-2016年某院鲍曼不动杆菌的临床分布及耐药性变迁 被引量:4

Distribution and antimicrobial susceptibility of Acinetobacter baumannii from 2014 to 2016
下载PDF
导出
摘要 目的监测并分析2014-2016年我院鲍曼不动杆菌分布及其药物敏感性,为临床合理选用抗菌药物提供依据。方法用WHONET5.6软件分析2014-2016年苏北人民医院分离的1461株鲍曼不动杆菌。结果 1461例鲍曼不动杆菌分离株,主要的标本来源是痰液(1092株,74.74%),主要分布科室是ICU(381株,26.1%)。鲍曼不动杆菌对多种抗菌药物耐药,在不同年度中,2015年相对于2014年鲍曼不动杆菌对大多数抗菌药物耐药性和分离率均有所下降,但是2016年却出现明显上升。结论鲍曼不动杆菌耐药形势严峻,特别是对ICU的病人构成了严重的威胁,导致病死率及医药花费增加,我们应做好监测,合理选择抗菌药物,做好感染控制。 Objective To analyze the characteristics of distribution and antimicrobial agents susceptibility of Acine-tobacter baumannii isolates in different clinical departments in our hospital from 2014 to 2016,so as to provide the latest evidence of clinical rational use of antibiotics.Methods 1461 strains of acinetobacter baumannii isolated from the sam-ples in Jan 1,2014 toDec 31 ,2016 of subei people's hospital were reanalyzed using WHONET 5.6 software.Results 1461 strains of acinetobacter baumannii were mainly isolated from sputum (1092strains,74.74%),the main distribution department is ICU (381 strains,26.1%).Acinetobacter baumannii is resistant to many kinds of antimicrobial agents, the most drug resistance of acinetobacter baumannii in 2015 were lower than those in 2014,but a significant rise in 2016.Conclusion The phenomenon of drug resistance withacinetobacter baumannii was serious,especially inICU,It is a serious threat for patients ,making fatality rate and medical cost increased,we should do well in monitoring,choosing of antimicrobial agents reasonable and controling the infection control.
出处 《中国实验诊断学》 2017年第12期2109-2111,共3页 Chinese Journal of Laboratory Diagnosis
基金 江苏省苏北人民医院科研项目(Yzucms201130)
关键词 鲍曼不动杆菌 抗菌药物 耐药性 Acinetobacter baumannii Pathogens Antimicrobial resistance
  • 相关文献

参考文献7

二级参考文献120

  • 1张小江,徐英春,俞云松,杨青,汪复,朱德妹,倪语星,孙景勇,孙自镛,简翠,胡云建,艾效曼,张泓,李万华,贾蓓,黄文祥,王传清,王爱敏,魏莲花,吴玲,卓超,苏丹虹,张朝霞,季萍,徐元宏,熊自忠,沈继录,单斌,杜艳.2009年中国CHINET鲍曼不动杆菌细菌耐药性监测[J].中国感染与化疗杂志,2010,10(6):441-446. 被引量:137
  • 2汪复.2005中国CHINET细菌耐药性监测结果[J].中国感染与化疗杂志,2006,6(5):289-295. 被引量:285
  • 3Peleg AY, Seifert H, Paterson DLAeinetobaeter baumannii: emergence of a successful pathogen. Clin Micmbiol Rev,2008,21 : 538-582.
  • 4Falagas ME, Koletsi PK, Bliziotis IA.The diversity of definitions of muhidrug-resistant(MDR) and pandrug-resistant (PDR) Aeinetohaeter bsumannli and Pseudomonas aeruginosa.J Med Microbiol, 2006,55: 1619-1629.
  • 5Paterson DL, Doi Y.A step closer to extreme drug resistance(XDR) in gram-negative bacilli.Clin Infect Dis,2007,45: 1179-1181.
  • 6Falagas ME, Karageorgopoulos DE.Pandrug resistance(PDR), extensive drug resistance(XDR), and muhidrug resistance(MDR) among Gram- negative bacilli: need for international harmonization in terminology.Clin Infect Dis, 2008,46: 1121-1122; author reply 1122.
  • 7Zhou H, Yang Q, Yu YS, et al. Clonal Spread of Imipenem-resistant Aeinetobaeter baumannii among different cities of China.J Clin Mierubiol, 2007,45 : 4054-4057.
  • 8Perez F, Hujer AM, Hujer KM, et al.Global challenge of multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother, 2007,51: 3471-3484.
  • 9Munoz-Price LS, Robert AW.Aclinetobaeter Infection.N Engl J Med,2008,358: 1271-1281.
  • 10Guardado AR, Blanco A, Asensi V, et al.Muhidrug-resistant Aeinetohaeter meningitis in neurosurgical patients with intraventricular catheters: assessment of different treatments. J Antimicrob Chemother,2008,61 : 908-913.

共引文献607

同被引文献29

引证文献4

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部